Presentations & Publications

Publication

Lm-LLO-Based Immunotherapies and HPV-Associated Disease

Published in Hindawi Publishing Corporation Journal of Oncology, October 2012

Publication

Development of a live and highly attenuated Listeria monocytogenes-based vaccine for the treatment of Her2/neu-overexpressing cancers in human

Published in Cancer Gene Therapy, January 2011

Publication

Development of a live and highly attenuated Listeria monocytogenes-based vaccine for the treatment of Her2/neu-overexpressing cancers in human.

Published in Cancer Gene Therapy, January 2011

Publication

High Efficacy of a Listeria-Based Vaccine against Metastatic Breast Cancer Reveals a Dual Mode of Action

Published in Cancer Research, July 7, 2009

Publication

Multiple Effector Mechanisms Induced by Recombinant Listeria monocytogenes Anticancer Immunotherapeutics

Published in Advances in Applied Microbiology, 2009

Publication

The first clinical use of a live-attenuated Listeria monocytogenes vaccine: A Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix

Published in Vaccine, May 3, 2009

Publication

An Anti-VEGFR2/Flk-1 Listeria monocytogenes Anti-Angiogenesis Cancer Vaccine for the Treatment of Primary and Metastatic Her-2/neu Positive Breast Tumors in a Mouse Model

Published in the Journal of Immunology, May 1, 2009

Publication

An anti-vascular endothelial growth factor receptor 2/fetal liver kinase-1 Listeria monocytogenes anti-angiogenesis cancer vaccine for the treatment of primary and metastatic Her-2/neu+ breast tumors in a mouse model.

Published in the Journal of Immunology, May 1, 2009

Publication

A Novel Human Her-2/neu Chimeric Molecule Expressed by Listeria monocytogenes Can Elicit Potent HLA-A2 Restricted CD8-positive T cell Responses and Impact the Growth and Spread of Her-2/neu-positive Breast Tumors

Published in Clinical Cancer Research, February 1, 2009

Publication

Construction and Characterization of an Attenuated Listeria monocytogenes Strain for Clinical Use in Cancer Immunotherapy

Published in Clinical and Vaccine Immunology, January 2009

Publication

Listeria-based HPV-16 E7 vaccines limit autochthonous tumor growth in a transgenic mouse model for HPV-16 transformed tumors

Published in Vaccine, September 26, 2008

Publication

Development of a Listeria monocytogenes based vaccine against prostate cancer

Published in Cancer Immunology Immunotherapy, February 14, 2008

Publication

Two Listeria monocytogenes Vaccine Vectors That Express Different Molecular Forms of Human Papilloma Virus-16 (HPV-16) E7 Induce Qualitatively Different T Cell Immunity That Correlates with Their Ability to Induce Regression of Established Tumors Immortalized by HPV-16

Published in the Journal of Immunology, September 2001